Earnings Call · Q2 FY2026·2026-08-05

Q2 26EPS -43.37%·Rev n/aQ1 26EPS -100.00%*·Rev n/aQ4 25EPS +42.59%·Rev n/aQ3 25EPS -67.14%·Rev n/a⚠ consensus missing

Vir Biotechnology, Inc. VIR

Kiki Patel — Head of Investor Relations

Dr. Marianne De Backer — Chief Executive Officer

Brent Sabatini — Interim Principal Financial Officer

−3.8%1d on move date3d−2.4%5d−1.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VIR calls or request research access.

More VIR calls Browse calls Request research access